BGMS - MCAP CO - Bio Green Med Solution Inc

Bio Green Med Solution Inc (BGMS) specializes in developing medical products to combat oncology, leveraging advancements in cell cycle and blood therapy. Serving as the primary valuation tool, this price chart confirms a market value of 0.01. The business is protected by strict certification standards and patents, while the current R&D process is focused on scheduled trials of new inhibitor molecules.

Market capitalization determines the aggregate value of all an issuer's shares, reflecting the current market consensus on the scale of the business. This metric is calculated as the product of the current share price and the total number of outstanding shares. By analyzing the total market value of a business, an investor assesses the asset's liquidity. For Bio Green Med Solution Inc (BGMS), this metric confirms its status as a research center. The absence of proprietary manufacturing plants and a reliance on outsourcing make capitalization a key indicator of the investment attractiveness of the company's intellectual property.